Literature DB >> 23281348

Are tyrosine kinase inhibitors the better serotonin inhibitors?

Djuro Kosanovic, Ralph Schermuly.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23281348     DOI： 10.1164/rccm.201211-2058ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  3 in total

Review 1.  Update in pulmonary vascular diseases 2013.

Authors:  Paul M Hassoun; Paul T Schumacker
Journal:  Am J Respir Crit Care Med       Date:  2014-10-01       Impact factor: 21.405

2.  5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure.

Authors:  Wiebke Janssen; Yves Schymura; Tatyana Novoyatleva; Baktybek Kojonazarov; Mario Boehm; Astrid Wietelmann; Himal Luitel; Kirsten Murmann; Damian Richard Krompiec; Aleksandra Tretyn; Soni Savai Pullamsetti; Norbert Weissmann; Werner Seeger; Hossein Ardeschir Ghofrani; Ralph Theo Schermuly
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

3.  Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment.

Authors:  Georgia Pitsiou; Paul Zarogoulidis; Dimitris Petridis; Ioannis Kioumis; Sofia Lampaki; John Organtzis; Konstantinos Porpodis; Antonis Papaiwannou; Theodora Tsiouda; Wolfgang Hohenforst-Schmidt; Stylianos Kakolyris; Konstantinos Syrigos; Haidong Huang; Qiang Li; J Francis Turner; Konstantinos Zarogoulidis
Journal:  Drug Des Devel Ther       Date:  2014-10-07       Impact factor: 4.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.